Combined hormonal contraception and its effects on mood: a critical review

References

• Slap GB. Oral contraceptives and depression: impact, prevalence and cause. J Adolesc Health Care. 1981;2:53–64.
   PubMedGoogle Scholar
• Robinson SA, Dowell M, Pedulla D, et al. Do the emotional side-effects of hormonal contraceptives come from pharmacologic or psychological mechanisms? Med Hypotheses. 2004;63:268–273.
   PubMed Web of Science ®Google Scholar
• Sanders SA, Graham CA, Bass JL, et al. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception. 2001;64:51–58.
   PubMed Web of Science ®Google Scholar
• Rosenberg MJ, Waugh MS. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol. 1998;179:577–582.
   PubMed Web of Science ®Google Scholar
• Westhoff CL, Heartwell S, Edwards S, et al. Oral contraceptive discontinuation: do side effects matter? Am J Obstet Gynecol. 2007;196:412.e1–e7.
   PubMed Web of Science ®Google Scholar
• Graham CA, Ramos R, Bancroft J, et al. The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods. Contraception. 1995;52:363–369.
   PubMed Web of Science ®Google Scholar
• Keyes KM, Cheslack-Postava K, Westhoff C, et al. Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States. Am J Epidemiol. 2013;178:1378–1388.
   PubMed Web of Science ®Google Scholar
• Toffol E, Heikinheimo O, Koponen P, et al. Hormonal contraception and mental health: results of a population-based study. Hum Reprod. 2011;26:3085–3093.
   PubMed Web of Science ®Google Scholar
• Toffol E, Heikinheimo O, Koponen P, et al. Further evidence for lack of negative associations between hormonal contraception and mental health. Contraception. 2012;86:470–480.
   PubMed Web of Science ®Google Scholar
• Duke JM, Sibbritt DW, Young AF. Is there an association between the use of oral contraception and depressive symptoms in young Australian women? Contraception. 2007;75:27–31.
   PubMed Web of Science ®Google Scholar
• Svendal G, Berk M, Pasco JA, et al. The use of hormonal contraceptive agents and mood disorders in women. J Affect Disord. 2012;140:92–96.
   PubMed Web of Science ®Google Scholar
• Oddens BJ. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception. 1999;59:277–286.
   PubMed Web of Science ®Google Scholar
• Oinonen KA, Mazmanian D. Effects of oral contraceptives on daily self-ratings of positive and negative affect. J Psychosom Res. 2001;51:647–658.
   PubMed Web of Science ®Google Scholar
• Berenson AB, Odom SD, Radecki Breitkopf C, Rahman M. Physiologic and psychologic symptoms associated with use of injectable contraception and 20 microg oral contraceptive pills. Am J Obstet Gynecol. 2008;199:351.e1–e12.
   Web of Science ®Google Scholar
• Marriott A, Faragher EB. An assessment of psychological state associated with the menstrual cycle in users of oral contraception. J Psychosom Res. 1986;30:41–47.
   PubMed Web of Science ®Google Scholar
• Natale V, Albertazzi P. Mood swings across the menstrual cycle: a comparison between oral contraceptive users and non-users. Biol Rhythm Res. 2006;37:489–495.
   Web of Science ®Google Scholar
• Almagor M, Ben-Porath YS. Mood changes during the menstrual cycle and their relation to the use of oral contraceptive. J Psychosom Res. 1991;35:721–728.
   PubMed Web of Science ®Google Scholar
• Kulkarni J, Liew J, Garland KA. Depression associated with combined oral contraceptives – a pilot study. Aust Fam Physician. 2005;34:990.
   PubMedGoogle Scholar
• Wimberly YH, Cotton S, Wanchick AM, et al. Attitudes and experiences with levonorgestrel 100 microg/ethinyl estradiol 20 microg among women during a 3-month trial. Contraception. 2002;65:403–406.
   PubMed Web of Science ®Google Scholar
• Akerlund M, Rode A, Westergaard J. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol. Br J Obstet Gynaecol. 1993;100:832–838.
   PubMedGoogle Scholar
• Greco T, Graham CA, Bancroft J, et al. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol. Contraception. 2007;76:8–17.
   PubMed Web of Science ®Google Scholar
• Warner P, Bancroft J. Mood, sexuality, oral contraceptives and the menstrual cycle. J Psychosom Res. 1988;32:417–427.
   PubMed Web of Science ®Google Scholar
• Bancroft J, Rennie D. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms. J Psychosom Res. 1993;37:195–202.
   PubMed Web of Science ®Google Scholar
• Walker A, Bancroft J. Relationship between premenstrual symptoms and oral contraceptive use: a controlled study. Psychosom Med. 1990;52:86–96.
   PubMed Web of Science ®Google Scholar
• Coffee AL, Kuehl TJ, Willis S, et al. Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen. Am J Obstet Gynecol. 2006;195:1311–1319.
   PubMed Web of Science ®Google Scholar
• Sabatini R, Cagiano R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception. 2006;74:220–223.
   PubMed Web of Science ®Google Scholar
• Lopez LM, Grimes DA, Gallo MF, et al. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2013;30:CD003552.
   Google Scholar
• Urdl W, Apter D, Alperstein A, et al. Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception. Eur J Obstet Gynecol Reprod Biol. 2005;121:202–210.
   PubMed Web of Science ®Google Scholar
• Sucato GS, Land SR, Murray PJ, et al. Adolescents' experiences using the contraceptive patch versus pills. J Pediatr Adolesc Gynecol. 2011;24:197–203.
   PubMed Web of Science ®Google Scholar
• Creinin MD, Meyn LA, Borgatta L, et al. Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial. Obstet Gynecol. 2008;111:267–277.
   PubMed Web of Science ®Google Scholar
• Shahnazi M, Khalili AF, Kochaksaraei FR, et al. A comparison of second and third generations combined oral contraceptive pills effect on mood. Iran Red Crescent Med J. 2014;16:e13628.
   PubMed Web of Science ®Google Scholar
• Deijen JB, Duyn KJ, Jansen WA, et al. Use of a monophasic, low-dose oral contraceptive in relation to mental functioning. Contraception. 1992;46:359–367.
   PubMed Web of Science ®Google Scholar
• Kelly S, Davies E, Fearns S, et al. Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study. Clin Drug Investig. 2010;30:325–336.
   PubMed Web of Science ®Google Scholar
• Sangthawan M, Taneepanichskul S. A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 microg on premenstrual symptoms. Contraception. 2005;71:1–7.
   PubMed Web of Science ®Google Scholar
• Borenstein J, Yu H-T, Wade S, et al. Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life. J Reprod Med. 2003;48:79–85.
   PubMed Web of Science ®Google Scholar
• Skrzypulec V, Drosdzol A. Evaluation of the quality of life and sexual functioning of women using a 30-microg ethinyloestradiol and 3-mg drospirenone combined oral contraceptive. Eur J Contracept Reprod Health Care. 2008;13:49–57.
   PubMed Web of Science ®Google Scholar
• Zimmerman Y, Foidart J-M, Pintiaux A, et al. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: II. Clinical effects. Contraception. 2015;91:134–142.
   PubMed Web of Science ®Google Scholar
• Witjes H, Creinin MD, Sundstrom-Poromaa I, et al. Comparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea. Eur J Contracept Reprod Health Care. 2015;20:296–307.
   PubMed Web of Science ®Google Scholar
• Kristjansdottir J, Olsson GI, Sundelin C, et al. Self-reported health in adolescent girls varies according to the season and its relation to medication and hormonal contraception – a descriptive study. Eur J Contracept Reprod Health. 2013;18:343–354.
   PubMed Web of Science ®Google Scholar
• Ott MA, Shew ML, Ofner S, et al. The influence of hormonal contraception on mood and sexual interest among adolescents. Arch Sex Behav. 2008;37:605–613.
   PubMed Web of Science ®Google Scholar
• Joffe H, Cohen LS, Harlow BL. Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration. Am J Obstet Gynecol. 2003;189:1523–1530.
   PubMed Web of Science ®Google Scholar
• Trossarelli GF, Gennarelli G, Benedetto C, et al. Climacteric symptoms and control of the cycle in women aged 35 years or older taking an oral contraceptive with 0.150 mg desogestrel and 0.020 mg ethinylestradiol. Contraception. 1995;51:13–18.
   PubMed Web of Science ®Google Scholar
• Cinar N, Harmanci A, Demir B, et al. Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study. Hum Reprod. 2012;27:1840–1845.
   PubMed Web of Science ®Google Scholar
• O’Connell K, Davis AR, Kerns J. Oral contraceptives: side effects and depression in adolescent girls. Contraception 2007;75:299–304.
   PubMed Web of Science ®Google Scholar
• Graham CA, Sherwin BB. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res. 1992;36:257–266.
   PubMed Web of Science ®Google Scholar
• Coffee AL, Sulak PJ, Kuehl TJ. Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen. Contraception. 2007;75:444–449.
   PubMed Web of Science ®Google Scholar
• Nyberg S. Mood and physical symptoms improve in women with severe cyclical changes by taking an oral contraceptive containing 250 mcg norgestimate and 35 mcg ethinyl estradiol. Contraception. 2013;87:773–781.
   PubMed Web of Science ®Google Scholar
• Wiebe ER, Brotto LA, MacKay J. Characteristics of women who experience mood and sexual side effects with use of hormonal contraception. J Obstet Gynaecol Can. 2011;33:1234–1240.
   PubMedGoogle Scholar
• Gingnell M, Engman J, Frick A, et al. Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill – a double-blinded, placebo-controlled randomised trial of a levonorgestrel-containing combined oral contraceptive. Psychoneuroendocrinology. 2013;38:1133–1144.
   PubMed Web of Science ®Google Scholar
• Borgstrom A, Kask K, Gulinello M, et al. Patients with adverse mood effects from combined oral contraceptives have lower levels of prepulse inhibition than healthy controls. Psychoneuroendocrinology. 2008;33:487–496.
   PubMed Web of Science ®Google Scholar
• Rapkin AJ, Morgan M, Sogliano C, et al. Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes. Fertil Steril. 2006;85:1371–1378.
   PubMed Web of Science ®Google Scholar
• Segebladh B, Borgstrom A, Odlind V, et al. Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives. Contraception. 2009;79:50–55.
   PubMed Web of Science ®Google Scholar
• Borgstrom A, Odlind V, Ekselius L, et al. Adverse mood effects of combined oral contraceptives in relation to personality traits. Eur J Obstet Gynecol Reprod Biol. 2008;141:127–130.
   PubMed Web of Science ®Google Scholar
• Stidham Hall K, O’Connell White K, Rickert VI, et al. Influence of depressed mood and psychological stress symptoms on perceived oral contraceptive side effects and discontinuation in young minority women. Contraception. 2012;86:518–525.
   PubMed Web of Science ®Google Scholar
• Young EA, Kornstein SG, Harvey AT, et al. Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. Psychoneuroendocrinology. 2007;32:843–853.
   PubMed Web of Science ®Google Scholar
• Ernst U, Baumgartner L, Bauer U, et al. Improvement of quality of life in women using a low-dose desogestrel-containing contraceptive: results of an observational clinical evaluation. Eur J Contracept Reprod Health Care. 2002;7:238–244.
   PubMed Web of Science ®Google Scholar
• Huber JC, Heskamp MS, Schramm GAK. Effect of an oral contraceptive with chlormadinone acetate on depressive mood: analysis of data from four observational studies. Clin Drug Investig. 2008;28:783–791.
   PubMed Web of Science ®Google Scholar
• Cheslack-Postava K, Keyes KM, Lowe SR, et al. Oral contraceptive use and psychiatric disorders in a nationally representative sample of women. Arch Womens Ment Health. 2015;18:103–111.
   PubMed Web of Science ®Google Scholar
• Francis J, Presser L, Malbon K, et al. An exploratory analysis of contraceptive method choice and symptoms of depression in adolescent females initiating prescription contraception. Contraception. 2015;91:336–343.
   PubMed Web of Science ®Google Scholar
• Garbers S, Correa N, Tobier N, et al. Association between symptoms of depression and contraceptive method choices among low-income women at urban reproductive health centers. Matern Child Health J. 2010;14:102–109.
   PubMed Web of Science ®Google Scholar
• Kendler KS, Martin NG, Heath AC, et al. A twin study of the psychiatric side effects of oral contraceptives. J Nerv Ment Dis. 1988;176:153–160.
   PubMed Web of Science ®Google Scholar
• Oinonen KA. Putting a finger on potential predictors of oral contraceptive side effects: 2D:4D and middle-phalangeal hair. Psychoneuroendocrinology. 2009;34:713–726.
   PubMed Web of Science ®Google Scholar
• Elaut E, Buysse A, De Sutter P, et al. Relation of androgen receptor sensitivity and mood to sexual desire in hormonal contraception users. Contraception. 2012;85:470–479.
   PubMed Web of Science ®Google Scholar